DSMA Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €114.50 |
| 52 Week High | €157.35 |
| 52 Week Low | €105.88 |
| Beta | 0.72 |
| 1 Month Change | -3.27% |
| 3 Month Change | -3.54% |
| 1 Year Change | -27.23% |
| 3 Year Change | -3.29% |
| 5 Year Change | 29.12% |
| Change since IPO | 161.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| DSMA | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 2.8% |
| 1Y | -27.2% | -37.7% | 1.1% |
Return vs Industry: DSMA exceeded the UK Chemicals industry which returned -38.1% over the past year.
Return vs Market: DSMA underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| DSMA volatility | |
|---|---|
| DSMA Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: DSMA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DSMA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG, a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants.
DSM-Firmenich AG Fundamentals Summary
| DSMA fundamental statistics | |
|---|---|
| Market cap | €763.73m |
| Earnings (TTM) | €454.00m |
| Revenue (TTM) | €8.39b |
1.7x
P/E Ratio0.1x
P/S RatioIs DSMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSMA income statement (TTM) | |
|---|---|
| Revenue | €8.39b |
| Cost of Revenue | €5.70b |
| Gross Profit | €2.69b |
| Other Expenses | €2.24b |
| Earnings | €454.00m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 02, 2023
| Earnings per share (EPS) | 67.80 |
| Gross Margin | 32.06% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 26.6% |
How did DSMA perform over the long term?
See historical performance and comparison